Krishna Institute of Medical Sciences Croissance future
Future contrôle des critères 5/6
Krishna Institute of Medical Sciences devrait augmenter ses bénéfices et son chiffre d'affaires de 24.7% et de 22.2% par an respectivement. Le BPA devrait croître de de 1.7% par an. Le rendement des capitaux propres devrait être 19.3% dans 3 ans.
Informations clés
24.7%
Taux de croissance des bénéfices
1.7%
Taux de croissance du BPA
| Healthcare croissance des bénéfices | 27.5% |
| Taux de croissance des recettes | 22.2% |
| Rendement futur des capitaux propres | 19.3% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 12 Nov 2024 |
Mises à jour récentes de la croissance future
Krishna Institute of Medical Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 13
Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 10Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 08Recent updates
Krishna Institute of Medical Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 13There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump
Sep 05We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right
Aug 23Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 10Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?
Jul 02Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon
Jun 12Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?
Apr 28We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)
Apr 10Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)
Feb 29Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 08Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Jan 23Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist
Nov 21Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?
Aug 23Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)
Aug 02Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher
Apr 01Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital
Dec 14Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report
Aug 13Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency
Aug 12Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors
Jul 02Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected
May 08Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 3/31/2027 | 47,176 | 6,287 | 3,836 | 9,626 | 9 |
| 3/31/2026 | 37,985 | 4,673 | 2,720 | 7,564 | 13 |
| 3/31/2025 | 30,701 | 3,889 | -2,967 | 6,423 | 11 |
| 9/30/2024 | 27,053 | 3,313 | -2,409 | 4,964 | N/A |
| 6/30/2024 | 25,805 | 3,159 | N/A | N/A | N/A |
| 3/31/2024 | 24,981 | 3,101 | -1,262 | 5,211 | N/A |
| 12/31/2023 | 24,403 | 3,379 | N/A | N/A | N/A |
| 9/30/2023 | 23,966 | 3,421 | -2,263 | 4,621 | N/A |
| 6/30/2023 | 23,082 | 3,472 | N/A | N/A | N/A |
| 3/31/2023 | 21,977 | 3,363 | -1,424 | 4,321 | N/A |
| 12/31/2022 | 19,941 | 3,237 | N/A | N/A | N/A |
| 9/30/2022 | 18,255 | 3,289 | 741 | 3,693 | N/A |
| 6/30/2022 | 16,732 | 3,135 | N/A | N/A | N/A |
| 3/31/2022 | 16,508 | 3,327 | 1,537 | 3,240 | N/A |
| 12/31/2021 | 16,370 | 3,098 | N/A | N/A | N/A |
| 9/30/2021 | 16,041 | 2,774 | 2,318 | 3,488 | N/A |
| 6/30/2021 | 16,020 | 2,792 | N/A | N/A | N/A |
| 3/31/2021 | 13,299 | 2,012 | 2,615 | 3,560 | N/A |
| 12/31/2020 | 12,412 | 1,721 | 3,180 | 3,774 | N/A |
| 3/31/2020 | 11,227 | 1,192 | 1,495 | 2,015 | N/A |
| 3/31/2019 | 9,204 | -477 | 566 | 1,339 | N/A |
| 3/31/2018 | 6,652 | -474 | N/A | 1,058 | N/A |
| 3/31/2017 | 5,689 | 326 | N/A | 815 | N/A |
| 3/31/2016 | 5,145 | 266 | N/A | 955 | N/A |
| 3/31/2015 | 4,222 | 56 | N/A | 639 | N/A |
| 3/31/2014 | 3,569 | 69 | N/A | 778 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de KIMS ( 24.7% par an) est supérieure au taux d'épargne ( 6.7% ).
Bénéfices vs marché: Les bénéfices de KIMS ( 24.7% par an) devraient croître plus rapidement que le marché Indian ( 17.9% par an).
Croissance élevée des bénéfices: Les bénéfices de KIMS devraient augmenter de manière significative au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de KIMS ( 22.2% par an) devrait croître plus rapidement que le marché Indian ( 10.5% par an).
Croissance élevée des revenus: Le chiffre d'affaires de KIMS ( 22.2% par an) devrait croître plus rapidement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de KIMS devrait être faible dans 3 ans ( 19.3 %).